DCM
NBSE

DME Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

DME Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-136,350
Closed -$61.3K – 45
2024
Q1 		$61.3K Buy
+136,350
New +$61.3K ﹤0.01% 40